Analystreport

Turning Point Therapeutics, Inc. (NASDAQ: TPTX) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating on the stock.

Turning Point Therapeutics, Inc. - Common stock  (TPTX) 
Last turning point therapeutics, inc. - common stock earnings: 3/16 09:00 am Check Earnings Report